SCHEMBL24913293

SCHEMBL24913293

BC(C)(C)c1cnc(-c2ccccc2C)cc1C(B)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 13/20 0.43
▸ CYP2C19 P33261 10/20 0.43
▸ CYP2D6 P10635 8/20 0.43
▸ CYP3A4 P08684 8/20 0.43
▸ CLK4 Q9HAZ1 6/20 0.43
▸ ALDH1A1 P00352 5/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ ALOX15 P16050 2/20 0.43
▸ MAPK1 P28482 4/20 0.40
▸ TSHR P16473 3/20 0.40
▸ METAP2 P50579 2/20 0.40
▸ IDO1 P14902 1/20 0.40
▸ TP53 P04637 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ TGFBR1 P36897 1/20 0.37
▸ HPGD P15428 4/20 0.37
▸ MAPT P10636 3/20 0.37
▸ LMNA P02545 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ MEN1 O00255 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25968127 0.87 CYP1A2 (0.43) CYP1A2CYP2C19CYP2D6CYP3A4CLK4
SCHEMBL24160881 0.84 CYP1A2 (0.41) CYP1A2CYP2C19CYP2D6CYP3A4CLK4
SCHEMBL26165300 0.83 CYP1A2 (0.45) CYP1A2CYP2C19CYP2D6CYP3A4CLK4
SCHEMBL23255785 0.80 CYP1A2 (0.45) CYP1A2CYP2C19CYP2D6CYP3A4CLK4
SCHEMBL26147133 0.78 CYP1A2 (0.41) CYP1A2CYP2C19CYP2D6CYP3A4CLK4
SCHEMBL25497659 0.78 CYP1A2 (0.41) CYP1A2CYP2C19CYP2D6CYP3A4CLK4
SCHEMBL22080319 0.78 LDHA (0.42) ALDH1A1IDO1MEN1NPC1RAB9A
SCHEMBL22037131 0.77 CYP1A2 (0.40) CYP1A2CYP2C19CYP2D6CYP3A4CLK4
SCHEMBL16716059 0.77 CYP1A2 (0.51) CYP1A2CYP2C19CYP2D6CYP3A4CLK4
SCHEMBL25990867 0.77 CYP1A2 (0.38) CYP1A2CYP2C19CYP2D6CYP3A4CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230345812-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-26 — — US disclosed
US-20230322829-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-12 — — US disclosed
US-20230263049-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-08-17 — — US disclosed
US-20230263048-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-08-17 — — US disclosed
US-11718634-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-08 — — US disclosed
US-20230142498-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-05-11 — — US disclosed
US-20230130017-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-04-27 — — US disclosed
US-20230020526-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-01-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230345812-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OPRD1, OCIAD2 CYP1A2 1308/4885CYP2C19 3138/4885CYP2D6 2945/4885
US-20230020526-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES RO60, RPS10, SOD1 CYP1A2 2614/4885CYP2C19 3551/4885CYP2D6 2639/4885
US-20230130017-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, SSB CYP1A2 872/4885CYP2C19 1631/4885CYP2D6 1351/4885
US-20230263048-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, ODC1 CYP1A2 181/4885CYP2C19 292/4885CYP2D6 477/4885
US-20230142498-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, LEF1 CYP1A2 723/4885CYP2C19 1153/4885CYP2D6 1135/4885
US-20230263049-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OSBPL3, OCIAD1, OSBP CYP1A2 430/4885CYP2C19 619/4885CYP2D6 1138/4885
US-20230322829-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, ICOSLG CYP1A2 1226/4885CYP2C19 1869/4885CYP2D6 1091/4885
US-11718634-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, ICOSLG CYP1A2 1172/4885CYP2C19 1619/4885CYP2D6 1128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback